PRCT

Procept BioRobotics Corp

19.96

Oct 23 • 3:59 PM ET -0.07 (-0.35%)

20.17

Aftermarket • 7:59 PM ET +0.21 (1.05%)

Healthcare Medical Devices USA Small NASD

Peers: BSX TFX PROF ISRG SSII CNMD SYK SIBN MDT BDX

| Held by: VTI IWM VB VBK VXF IWO BOTZ SCHA VTWO IHI

Scroll to Statements

Index	RUT
Market Cap	1.14B
Enterprise Value	992.77M
Income	-109.75M
Sales	337.34M
Book/sh	5.94
Cash/sh	3.98
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	888
IPO	Sep 15, 2021

P/E	-
Forward P/E	-
PEG	-
P/S	3.39
P/B	3.36
P/C	5.02
P/FCF	-
EV/EBITDA	-
EV/Sales	2.94
Quick Ratio	5.34
Current Ratio	6.54
Debt/Eq	0.23
LT Debt/Eq	0.22
Option/Short	Yes / Yes

EPS (ttm)	-1.95
EPS next Y	-1.15
EPS next Q	-0.39
EPS this Y	2.77%
EPS next Y	31.13%
EPS next 5Y	21.44%
EPS past 3/5Y	4.30% -7.02%
Sales past 3/5Y	60.14% 109.04%
EPS Y/Y TTM	-25.05%
Sales Y/Y TTM	22.69%
EPS Q/Q	-33.31%
Sales Q/Q	19.34%
Earnings	Nov 04 AMC
EPS/Sales Surpr.	-1.75% 1.86%

Insider Own	4.63%
Insider Trans	0.83%
Inst Own	95.24%
Inst Trans	-5.90%
ROA	-22.12%
ROE	-30.24%
ROIC	-26.44%
Gross Margin	63.74%
Oper. Margin	-33.86%
Profit Margin	-32.54%
SMA20	9.47%
SMA50	2.11%
SMA200	-15.53%
Trades

Shs Outstand	57.25M
Shs Float	54.62M
Short Float	13.60%
Short Ratio	5.29
Short Interest	7.43M
52W High	38.11 -47.63%
52W Low	16.67 19.77%
Volatility	6.28% 5.94%
ATR (14)	1.09
RSI (14)	57.24
Beta	0.88
Rel Volume	0.55
Avg Volume	1.40M
Volume	773,786

Perf Week	13.60%
Perf Month	14.06%
Perf Quarter	12.83%
Perf Half Y	-18.06%
Perf YTD	-36.55%
Perf Year	-42.35%
Perf 3Y	-26.27%
Perf 5Y	-53.30%
Perf 10Y	-
Recom	2.47
Target Price	22.25
Prev Close	20.03
Price	19.96
Change %	-0.35%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-07-26	Initiated	Barclays	Overweight	$30
Aug-05-26	Downgrade	William Blair	Outperform → Mkt Perform
Aug-05-26	Downgrade	Wells Fargo	Overweight → Equal Weight	$19
Jul-28-26	Downgrade	UBS	Buy → Neutral	$20
Jul-06-26	Downgrade	Truist	Buy → Hold	$25
Jun-24-26	Initiated	Evercore ISI	Outperform	$30
Jun-11-26	Downgrade	Leerink Partners	Outperform → Market Perform	$29
Mar-06-26	Initiated	Robert W. Baird	Neutral	$30
Feb-26-26	Downgrade	Oppenheimer	Outperform → Perform
Feb-26-26	Downgrade	BofA Securities	Neutral → Underperform	$20
Dec-12-25	Initiated	UBS	Buy	$62
Dec-08-25	Downgrade	BofA Securities	Buy → Neutral	$38
Sep-02-25	Upgrade	Oppenheimer	Perform → Outperform	$60
Jul-09-25	Initiated	Stephens	Overweight	$70
Jul-07-25	Initiated	Oppenheimer	Perform
Dec-02-24	Initiated	Morgan Stanley	Overweight	$105
Nov-14-24	Initiated	Jefferies	Hold	$95
Aug-11-23	Initiated	Piper Sandler	Overweight	$42
May-31-23	Initiated	William Blair	Outperform
Oct-31-22	Initiated	BTIG Research	Neutral

Show Previous Ratings

Oct-12-26 04:05PM	PROCEPT BioRobotics to Report Third Quarter 2026 Financial Results on November 4th, 2026 (GlobeNewswire) +6.36%
Oct-07-26 10:00AM	Flutter upgraded, AppFolio downgraded: Wall Street's top analyst calls (The Fly)
Sep-17-26 03:00PM	Kaplan Fox Encourages PROCEPT BioRobotics Corporation (PRCT) Investors With Substantial Losses to Contact the Firm Before September 22, 2026 (Newsfile)
Sep-16-26 01:00PM	Kaplan Fox Reminds PROCEPT BioRobotics Corporation (PRCT) Investors That They Have Until September 22, 2026 to Move for Lead Plaintiff (Newsfile)
Sep-15-26 01:15PM	LAWSUIT NOTICE: NASDAQ: PRCT Investors who lost money with PROCEPT BioRobotics Corporation shares should contact the Shareholders Foundation (PR Newswire) -8.18%
01:45PM	Loading…
Aug-31-26 01:45PM	Kaplan Fox Encourages PROCEPT BioRobotics Corporation (PRCT) Investors Who Suffered Losses to Seek a Leadership Role Before September 22, 2026 (Newsfile)
Aug-17-26 08:00AM	PROCEPT BioRobotics to Attend the Baird 2026 Global Healthcare Conference on September 15, 2026 (GlobeNewswire)
Aug-13-26 04:41AM	PROCEPT BioRobotics Corporation Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - PRCT (PR Newswire)
Aug-11-26 07:15AM	PRCT Shareholders Have Rights - If You Lost Money Investing in PROCEPT BioRobotics Corporation Contact Robbins LLP for Information About Recovering Your Losses (PR Newswire) +5.44%
07:07AM	PRCT Investor Announcement: PROCEPT BioRobotics Sued on behalf of Investors to Recover Losses after Artificially Inflated Revenue Leads to 18% Stock Drop (PR Newswire)
Aug-05-26 01:45PM	Kaplan Fox Urges PROCEPT BioRobotics Corporation (PRCT) Investors Seeking Recovery to Contact the Firm Before September 28, 2026 (Newsfile) +5.80%
01:04AM	PROCEPT BioRobotics Corp (PRCT) (Q2 2026) Earnings Call Highlights: Strong HYDROS Demand Drives ... (GuruFocus.com)
Aug-04-26 04:05PM	PROCEPT BioRobotics Reports Second Quarter 2026 Financial Results (GlobeNewswire)
Aug-03-26 09:27AM	Earnings To Watch: PROCEPT BioRobotics Corp (PRCT) Q2 2026 -- GF Value Sees 552% Upside (GuruFocus.com)
Jul-29-26 10:33AM	Processa Pharmaceuticals Acquires Vidya Therapeutics and Secures $200 Million Financing to Advance BTK Inhibitor Pipeline (InvestorsHub)
07:30AM	Loading…
Jul-27-26 07:30AM	PROCEPT BioRobotics Corporation Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights PRCT (Business Wire) +5.99%
Jul-14-26 04:05PM	PROCEPT BioRobotics to Report Second Quarter 2026 Financial Results on August 4th, 2026 (GlobeNewswire) -9.00%
Jun-24-26 09:31AM	BlackBerry, Take-Two initiations among today's top calls on Wall Street (The Fly)
Jun-11-26 09:38AM	SpaceX initiated, Intel upgraded: Wall Street's top analyst calls (The Fly)
May-28-26 08:00AM	PROCEPT BioRobotics Advances Prostate Cancer Program with WATER IV Study Enrollment Completion and Expanded IDE Approval (GlobeNewswire)
May-14-26 08:00AM	AUA Guidelines Strengthen Recommendation for Aquablation Therapy (GlobeNewswire)
Apr-30-26 04:03PM	PROCEPT BioRobotics to Attend Three Upcoming Investor Conferences in May & June (GlobeNewswire) +10.73%
03:17AM	PROCEPT BioRobotics Corp (PRCT) Q1 2026 Earnings Call Highlights: Strong Revenue Growth Amidst ... (GuruFocus.com)
Apr-29-26 04:03PM	PROCEPT BioRobotics Reports First Quarter 2026 Financial Results (GlobeNewswire) -5.73%
Apr-28-26 09:24AM	PROCEPT BioRobotics Corp (PRCT) Q1 2026 Earnings Report Preview: What To Look For (GuruFocus.com)
Apr-09-26 04:05PM	PROCEPT BioRobotics to Report First Quarter 2026 Financial Results on April 29, 2026 (GlobeNewswire)
Mar-24-26 11:03AM	Sonder Capital Closes its Second Fund and Announces Participation from Major Healthcare Systems (PR Newswire)
Mar-23-26 07:00AM	EAU Guidelines Upgrade Aquablation Therapy to Strong Surgical Recommendation for BPH (GlobeNewswire)
Mar-16-26 12:27AM	Levi & Korsinsky Investigating Whether PROCEPT BioRobotics Corporation (PRCT) Misled Investors - Securities Law Violations Possible (Newsfile)
Mar-12-26 09:00AM	PROCEPT BioRobotics Announces International Launch of the HYDROS Robotic System, Expanding Global Access to AI-Enabled Aquablation Therapy (GlobeNewswire) -6.04%
08:18AM	Loading…
Mar-03-26 08:18AM	Procept BioRobotics price target lowered to $30 from $47 at Truist (TipRanks)
Mar-01-26 11:35AM	PROCEPT BioRobotics Investor Day: 2026 growth targets, higher ASPs, and profitability roadmap (MarketBeat)
Feb-26-26 04:34PM	Stocks Finish Mostly Lower as Nvidia Weighs on Chipmakers (Barchart) -15.12%
04:06PM	Robotics Play Procept Biorobotics Plummets On Hard-To-Stomach Update (Investor's Business Daily)
11:21AM	Stocks Pressured as Chipmakers Tumble (Barchart)
10:17AM	Stocks Mostly Lower as Nvidia Earnings Fail to Impress (Barchart)
07:55AM	PROCEPT BioRobotics Hosts 2026 Investor Day to Detail Multi-year Financial Outlook and Strategic Plan for Long-Term Growth (GlobeNewswire)
07:04AM	PROCEPT BioRobotics Stock Hits 52-Week Low - Here's Why (Benzinga)
02:11AM	PROCEPT BioRobotics Q4 Earnings Call Highlights (MarketBeat)
12:04AM	PROCEPT BioRobotics Corp (PRCT) Q4 2025 Earnings Call Highlights: Navigating Growth and Challenges (GuruFocus.com)
Feb-25-26 07:25PM	PROCEPT BioRobotics Corporation (PRCT) Reports Q4 Loss, Lags Revenue Estimates (Zacks)
04:02PM	PROCEPT BioRobotics Reports Fourth Quarter 2025 Financial Results and Updates 2026 Revenue Guidance (GlobeNewswire)
Feb-24-26 10:20AM	PROCEPT BioRobotics Corporation (PRCT): A Bull Case Theory (Insider Monkey)
Feb-23-26 04:03PM	PROCEPT BioRobotics Announces Updated Dates for 4Q25 Earnings Conference Call and Investor Day (GlobeNewswire)
07:23AM	Earnings To Watch: PROCEPT BioRobotics Corp (PRCT) Reports Q4 2025 Result (GuruFocus.com)
Feb-12-26 08:09AM	Wall Street Has a Positive Opinion on ?PROCEPT BioRobotics (PRCT), Here's Why (Insider Monkey)
Feb-05-26 08:15AM	IQVIA Holdings (IQV) Q4 Earnings and Revenues Top Estimates (Zacks) -5.29%
Feb-04-26 05:40PM	Steris (STE) Meets Q3 Earnings Estimates (Zacks)
04:03PM	PROCEPT BioRobotics to Attend the TD Cowen 46th Annual Health Care Conference and the 2026 Leerink Global Healthcare Conference (GlobeNewswire)
Jan-26-26 04:03PM	PROCEPT BioRobotics to Host 4Q25 Earnings Conference Call on February 24, 2026, and Investor Day on February 25, 2026, in New York City (GlobeNewswire)
Jan-08-26 09:12AM	Truist Maintains Buy Rating on Procept BioRobotics (PRCT) Amid MedTech Sector Rotation (Insider Monkey)
Jan-07-26 08:41AM	ISRG Trading 4% Below All-Time High: Should You Buy the Stock Now? (Zacks)
Dec-22-25 06:50AM	Promising Growth Forecasts Leading to Analysts' Optimism for Procept Biorobotics (PRCT) (Insider Monkey) +6.86%
Dec-15-25 07:03AM	3 Underrated Robotics Stocks Poised for Huge Gains (MarketBeat)
Nov-20-25 04:03PM	PROCEPT BioRobotics to Present at Upcoming 37th Annual Piper Sandler Healthcare Conference on December 2, 2025 (GlobeNewswire) +7.06%
Nov-18-25 05:07AM	Piper Sandler Reiterates a Buy on PROCEPT BioRobotics Corporation (PRCT) (Insider Monkey)
Nov-05-25 12:04AM	PROCEPT BioRobotics Corp (PRCT) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amid ... (GuruFocus.com) -9.74%
Nov-04-25 05:40PM	PROCEPT BioRobotics Corporation (PRCT) Reports Q3 Loss, Beats Revenue Estimates (Zacks)
04:03PM	PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance (GlobeNewswire)
Oct-30-25 10:00AM	Mettler-Toledo (MTD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Oct-29-25 09:00AM	2 Robotics Stocks Riding the Sensor and Medical Boom (Motley Fool)
Oct-28-25 10:00AM	Earnings Preview: PROCEPT BioRobotics Corporation (PRCT) Q3 Earnings Expected to Decline (Zacks)
Oct-20-25 11:08PM	Truist Lowers PT on PROCEPT BioRobotics Corporation (PRCT) to $50 From $64, Keeps a Buy Rating (Insider Monkey) +5.31%
09:20AM	Stereotaxis Rolls Out Synchrony System in EU and Files for FDA Approval (Zacks)
Oct-15-25 04:03PM	PROCEPT BioRobotics to Report Third Quarter 2025 Financial Results on November 4, 2025 (GlobeNewswire)
Sep-15-25 09:01AM	ISRG Stock Down More than 13% in 3 Months: How to Play the Stock? (Zacks)
Sep-04-25 06:13AM	Your Move, Human: Analysts See Growth Potential in These 2 Robotics Stocks (TipRanks)
Aug-27-25 08:29AM	SP Platform's 88% Procedure Growth: The Next Frontier for ISRG? (Zacks)
Aug-21-25 12:30PM	Wall Street short sellers have been crushed in 2025. Better days might be coming. (MarketWatch)
11:15AM	PROCEPT BioRobotics (PRCT) Outlook Adjusted as System Replacement Forecasts Shift (Insider Monkey)
Aug-13-25 12:08PM	Leerink Partners Reiterates a Buy Rating on PROCEPT BioRobotics (PRCT) (Insider Monkey)
Aug-06-25 05:45PM	PROCEPT BioRobotics Corporation (PRCT) Reports Q2 Loss, Lags Revenue Estimates (Zacks) -5.05% -13.35%
04:03PM	PROCEPT BioRobotics Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance (GlobeNewswire)
Aug-05-25 08:15AM	AxoGen (AXGN) Beats Q2 Earnings and Revenue Estimates (Zacks)
Aug-04-25 05:45PM	Si-Bone (SIBN) Reports Q2 Loss, Beats Revenue Estimates (Zacks)
Jul-31-25 10:30AM	Envoy Medical, Inc. (COCH) Reports Q2 Loss, Tops Revenue Estimates (Zacks) -5.53%
Jul-30-25 10:00AM	Will PROCEPT BioRobotics Corporation (PRCT) Report Negative Earnings Next Week? What You Should Know (Zacks)
Jul-25-25 07:00AM	Edwards loses longtime TAVR leader Larry Wood (MedTech Dive)
Jul-24-25 06:00PM	PROCEPT BioRobotics President and CEO Dr. Reza Zadno to Retire, Company Appoints Larry L. Wood as New President and CEO (GlobeNewswire)
Jul-23-25 08:00AM	Ambulatory Surgery Center Completes WATER IV Trial Procedures for Prostate Cancer with Aquablation Therapy (GlobeNewswire)
Jul-21-25 04:03PM	PROCEPT BioRobotics to Report Second Quarter 2025 Financial Results on August 6, 2025 (GlobeNewswire)
Jul-14-25 09:15PM	Aquablation Therapy's Assigned Category I Code in 2026 Medicare Proposed Physician Fee Schedule (GlobeNewswire)
Apr-29-25 04:03PM	PROCEPT BioRobotics to Attend Four Upcoming Investor Conferences in May & June (GlobeNewswire)
Apr-24-25 04:03PM	PROCEPT BioRobotics' Aquablation Therapy Spotlighted at 2025 AUA Annual Meeting Along with Expert-Led Workshops (GlobeNewswire) -5.64%
02:37PM	PROCEPT BioRobotics Corporation (PRCT) Q1 2025 Earnings Call Transcript (Seeking Alpha)
08:15AM	PROCEPT BioRobotics Corporation (PRCT) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
07:00AM	PROCEPT BioRobotics Reports First Quarter 2025 Financial Results and Increases 2025 Revenue Guidance (GlobeNewswire)
Apr-10-25 04:03PM	PROCEPT BioRobotics Announces Investor Event at 2025 AUA Annual Meeting at the Aria Resort in Las Vegas (GlobeNewswire) -7.22%
Mar-29-25 06:03PM	PROCEPT BioRobotics (PRCT): One of the Best Robotics Stocks to Buy According to Billionaires (Insider Monkey)
Mar-24-25 08:00AM	WATER III Randomized-Controlled Trial Results Announced at European Association of Urology Comparing Aquablation Therapy to Laser Enucleation (GlobeNewswire)
Mar-20-25 09:05AM	Invesco Health Care Fund Q4 2024 Commentary (SeekingAlpha)
Mar-14-25 08:00AM	PROCEPT BioRobotics Announces Investor Event at 2025 AUA Annual Meeting in Las Vegas, Nevada (GlobeNewswire)
Feb-26-25 09:32AM	Q4 2024 Procept Biorobotics Corp Earnings Call (Thomson Reuters StreetEvents) +8.61%
02:15AM	PROCEPT BioRobotics Corp (PRCT) Q4 2024 Earnings Call Highlights: Record Revenue Growth and ... (GuruFocus.com)
Feb-25-25 05:25PM	PROCEPT BioRobotics Corporation (PRCT) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:02PM	PROCEPT BioRobotics Reports Fourth Quarter and Full Year 2024 Results (GlobeNewswire)
01:22AM	PROCEPT BioRobotics Corp (PRCT) Q4 2024 Earnings Report Preview: What To Expect (GuruFocus.com)

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Nouri Alaleh	EVP, CLO, CORP. SEC.	Sep 09 '26	Sale	20.95	297	6,223	127,737	Sep 10 04:45 PM
Templin Barry L	EVP, Chief Technology Officer	Sep 09 '26	Sale	20.95	373	7,815	94,826	Sep 10 04:44 PM
Waters Kevin	EVP, CFO	Sep 09 '26	Sale	20.95	373	7,815	180,355	Sep 10 04:42 PM
Nouri Alaleh	Officer	Sep 09 '26	Proposed Sale	20.95	297	6,223		Sep 09 03:15 PM
Templin Barry L	Officer	Sep 09 '26	Proposed Sale	20.95	373	7,816		Sep 09 03:14 PM
Waters Kevin	Officer	Sep 09 '26	Proposed Sale	20.95	373	7,816		Sep 09 03:12 PM
Wood Larry L	President, CEO	Aug 07 '26	Buy	20.85	23,900	498,315	23,900	Aug 10 06:07 AM
Nouri Alaleh	EVP, CLO, CORP. SEC.	Jun 08 '26	Sale	28.48	285	8,117	105,069	Jun 10 04:21 PM
Waters Kevin	EVP, CFO	Jun 08 '26	Sale	28.48	357	10,167	151,201	Jun 10 04:18 PM
Templin Barry L	EVP, Chief Technology Officer	Jun 08 '26	Sale	28.48	358	10,195	68,953	Jun 10 04:15 PM
Nouri Alaleh	Officer	Jun 08 '26	Proposed Sale	28.48	285	8,117		Jun 08 04:34 PM
Waters Kevin	Officer	Jun 08 '26	Proposed Sale	28.48	357	10,167		Jun 08 04:09 PM
Templin Barry L	Officer	Jun 08 '26	Proposed Sale	28.48	358	10,195		Jun 08 03:26 PM
Nouri Alaleh	EVP, CLO, CORP. SEC.	Mar 19 '26	Sale	25.96	5,363	139,231	105,354	Mar 19 05:47 PM
Alalah Nouri	Officer	Mar 19 '26	Proposed Sale	26.17	5,363	140,349		Mar 19 04:57 PM
Nouri Alaleh	EVP, CLO, CORP. SEC.	Mar 17 '26	Sale	28.15	304	8,559	110,717	Mar 19 04:25 PM
Waters Kevin	EVP, CFO	Mar 17 '26	Sale	28.15	706	19,876	151,558	Mar 19 04:25 PM
Nouri Alaleh	Officer	Mar 17 '26	Proposed Sale	28.15	304	8,559		Mar 17 03:14 PM
Waters Kevin	Officer	Mar 17 '26	Proposed Sale	28.15	706	19,876		Mar 17 03:13 PM
Nouri Alaleh	EVP, CLO, CORP. SEC.	Mar 10 '26	Sale	25.65	3,243	83,197	111,021	Mar 12 04:02 PM
Alalah Nouri	Officer	Mar 10 '26	Proposed Sale	25.26	3,243	81,918		Mar 10 04:04 PM
Desai Antal Rohit	Director	Mar 05 '26	Buy	25.58	167,246	4,278,549	167,246	Mar 09 07:19 PM
Desai Antal Rohit	Director	Mar 06 '26	Buy	23.59	160,317	3,781,503	327,563	Mar 09 07:19 PM
Desai Antal Rohit	Director	Mar 09 '26	Buy	24.55	98,699	2,422,891	426,262	Mar 09 07:19 PM
Nouri Alaleh	EVP, CLO, CORP. SEC.	Mar 06 '26	Sale	23.70	6,892	163,353	114,264	Mar 09 05:43 PM
Waters Kevin	EVP, CFO	Mar 06 '26	Sale	23.70	6,721	159,300	152,264	Mar 09 05:40 PM
Nouri Alaleh	Officer	Mar 06 '26	Proposed Sale	23.70	6,892	163,353		Mar 06 04:19 PM
Waters Kevin	Officer	Mar 06 '26	Proposed Sale	23.70	6,721	159,300		Mar 06 04:07 PM

PROCEPT BioRobotics Corp. is a commercial-stage surgical robotics company, which engages in the development of transformative solutions in urology. It manufactures and sells the AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating BPH. The firm's proprietary AquaBeam Robotic System employs a single-use disposable handpiece to deliver its Aquablation therapy, which combines real-time, multidimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. The company was founded by Nikolai Aljuri and Rodney C. Perkins in 2007 and is headquartered in San Jose, CA.

PresidentMr. Larry L. Wood

Executive VP & CFOMr. Kevin Waters

EVPMs. Alaleh Nouri

Executive Vice President of OperationsMr. Christofer Christoforou

Executive VP & CTOMr. Barry Templin

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

PRCT

Procept BioRobotics Corp

Upgrade your Finviz experience